Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UCSB makes important advances in studies of retinal detachment

15.12.2004


Scientists at the University of California, Santa Barbara’s Neuroscience Research Institute are reporting significant advances in their studies of retinal detachment:

  • They have discovered that cellular changes that occur in the retinas of animals with retinal detachments also occur in humans. This implies that experimental therapies that reduce cellular damage in animals have a high likelihood of being successful in humans.
  • They have determined that oxygen therapy for retinal detachment, which they pioneered, can be highly successful in animals even when it is delayed, suggesting that it should be successful in humans as well.

In the January 2005 issue of Investigative Ophthalmology and Visual Science, the international team of scientists describes changes that occur in detached human retinas. In this study, Steven K. Fisher, professor of molecular, cellular and developmental biology, and Geoffrey P. Lewis, research scientist, headed the UCSB effort, collaborating with colleagues at the Moorfields Eye Hospital and the Institute of Ophthalmology at University College London.



Understanding the "glial" response is a key aspect of this study.

Glial cells are known as the "supporting cells" of the nervous system. The central nervous system (CNS) consists of both neurons and glial cells. Glial cells actually outnumber neurons in the CNS but their functions are poorly understood. It is known that glial cells surround neurons, hold them in place and supply nutrients to neurons. They insulate neurons from each other and also destroy and remove dead neurons.


The reaction of the glial cells to retinal detachment is critical to the success of surgery to correct retinal detachment. The glial response is part of an important medical condition called "proliferative vitreoretinopathy" (PVR). This condition is characterized by the growth of glial cells on the surface of the retina. In response to unknown stimuli, these cells begin to contract and can cause the retina to tear or re-detach. In humans, PVR is the most common cause of failure of retinal reattachment surgery. It occurs in five to 10 percent of all cases.

Essentially the glial cells form scar tissue in PVR. Scar tissue in one location causes the re-detachment of the retina, in another it blocks the regeneration of neurons and vision does not return. According to this and earlier studies, the data indicate that glial cell remodeling can play a clear role in the return of good vision following successful reattachment surgery. What has been a surprising new result in all of the recent studies is the extent of neuronal remodeling that occurs during the time the retina is detached.

"The structural remodeling of retinal neurons in animals following detachment has been assumed to alter synaptic connections between nerve cells and in doing so have an effect on visual outcome including reduced visual acuity or changes in color vision," said Lewis. Photoreceptors in the eyes are among the most highly metabolic cells in the body, using more energy than any others. Because of this, the UCSB researchers decided to test the use of extra oxygen to help maintain the cells after a retinal detachment. First reported by the UCSB researchers in 1999, the therapy has proved remarkably effective and is now being used by some ophthalmologists prior to surgery. Recently the UCSB team reported refinements of these results.

Normal room air has about 21 percent oxygen. In these first studies, the effects of oxygen were examined under "ideal" conditions. That is, oxygen therapy at 70 percent was begun immediately after creating a retinal detachment. However, these ideal conditions would not likely be encountered in a clinical situation because it would not be possible to administer oxygen to human patients immediately after a retinal detachment occurs.

Therefore, a new study was undertaken in which elevated oxygen was administered 24 hours after creating a detachment, thus more closely mimicking conditions commonly encountered in human patients. The results were published by the UCSB scientists in American Journal of Ophthalmology last summer. In this case, neuronal cell death and nerve cell remodeling was greatly reduced by comparison to the animals breathing normal room air, although the glial cell response was less affected than in the experiments with delivery of immediate elevated oxygen.

Assuming that it is desirable to reduce cell death and prevent the remodeling of nerve cells in detachment patients, the simple administration of elevated oxygen between the time of diagnosis and surgical repair may result in more rapid and improved recovery after reattachment surgery. Future research will include determining the effectiveness of this hyperoxia therapy when administered both before and after reattachment surgery, and methods for better inhibition of the undesirable cellular effects that lead to PVR.

This research has broad implications since the cell types involved (neurons and glia) are the same as those in the brain and spinal cord. The UCSB effort is one of a handful of research labs in the world that are studying retinal detachment in this way. The work at UCSB is unique in that the researchers have specialized using high resolution microscopy techniques to precisely map changes in protein expression and morphology in the cells.

Gail Gallessich | EurekAlert!
Further information:
http://www.ucsb.edu

More articles from Life Sciences:

nachricht Molecular evolution: How the building blocks of life may form in space
26.04.2018 | American Institute of Physics

nachricht Multifunctional bacterial microswimmer able to deliver cargo and destroy itself
26.04.2018 | Max-Planck-Institut für Intelligente Systeme

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

World's smallest optical implantable biodevice

26.04.2018 | Power and Electrical Engineering

Molecular evolution: How the building blocks of life may form in space

26.04.2018 | Life Sciences

First Li-Fi-product with technology from Fraunhofer HHI launched in Japan

26.04.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>